• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子和内皮抑素水平在良恶性腹水鉴别诊断中的临床意义。

Clinical significance of vascular endothelial growth factor and endostatin levels in the differential diagnosis of malignant and benign ascites.

机构信息

Department of Transfusion, The First Hospital of China Medical University, North Nanjing Street, No. 155, 110001 Shenyang, Liaoning, People's Republic of China.

出版信息

Med Oncol. 2012 Jun;29(2):1397-402. doi: 10.1007/s12032-011-9972-2. Epub 2011 May 10.

DOI:10.1007/s12032-011-9972-2
PMID:21556933
Abstract

The aim of this study is to evaluate the performance of VEGF and endostatin levels in the differential diagnosis of malignant and benign ascites. The study included 101 consecutive patients with malignant ascites (55.2 ± 15.8 years, 63 men and 38 women) and 81 patients with benign ascites (53.0 ± 17.2 years, 51 men and 30 women). VEGF and endostatin levels in serum and ascites were determined by a sandwich enzyme immunoassay technique using a commercially available assay kit. The serum VEGF, ascites VEGF, and ascites endostatin levels of patients with malignant ascites were significantly higher than those in patients with benign ascites (P < 0.001), but there was no difference in serum endostatin levels between the two groups (P = 0.267). Ascites endostatin levels correlated positively with ascites VEGF (r = 0.5193, P < 0.01), and serum endostatin showed a low correlation with serum VEGF (r = 0.3291, P < 0.01) in patients with malignant ascites. Areas under the ROC curves of ascites VEGF, ascites endostatin, serum VEGF, and serum endostatin were 0.890, 0.815, 0.694, and 0.552, respectively. The combination of ascites VEGF and endostatin improved the sensitivity up to 90.1%, the specificity up to 87.7%, and the accuracy up to 89.0% in the differential diagnosis of malignant and benign ascites. VEGF and endostatin levels in ascites appear to be suitable for differentiating between malignant and benign ascites, which can be applied to clinical examination.

摘要

本研究旨在评估 VEGF 和内皮抑素水平在良恶性腹水鉴别诊断中的作用。研究纳入 101 例恶性腹水患者(55.2±15.8 岁,男 63 例,女 38 例)和 81 例良性腹水患者(53.0±17.2 岁,男 51 例,女 30 例)。采用商用夹心酶联免疫吸附试验技术检测血清和腹水 VEGF 和内皮抑素水平。恶性腹水患者的血清 VEGF、腹水 VEGF 和腹水内皮抑素水平明显高于良性腹水患者(P<0.001),但两组血清内皮抑素水平无差异(P=0.267)。腹水内皮抑素水平与腹水 VEGF 呈正相关(r=0.5193,P<0.01),恶性腹水患者血清内皮抑素与血清 VEGF 呈低度相关(r=0.3291,P<0.01)。腹水 VEGF、腹水内皮抑素、血清 VEGF 和血清内皮抑素的 ROC 曲线下面积分别为 0.890、0.815、0.694 和 0.552。腹水 VEGF 和内皮抑素联合应用可将恶性和良性腹水的鉴别诊断敏感性提高至 90.1%,特异性提高至 87.7%,准确性提高至 89.0%。腹水 VEGF 和内皮抑素水平似乎适合于良恶性腹水的鉴别诊断,可应用于临床检查。

相似文献

1
Clinical significance of vascular endothelial growth factor and endostatin levels in the differential diagnosis of malignant and benign ascites.血管内皮生长因子和内皮抑素水平在良恶性腹水鉴别诊断中的临床意义。
Med Oncol. 2012 Jun;29(2):1397-402. doi: 10.1007/s12032-011-9972-2. Epub 2011 May 10.
2
The clinical significance of vascular endothelial growth factor in malignant ascites.血管内皮生长因子在恶性腹水中的临床意义
Tumour Biol. 2016 Mar;37(3):3719-25. doi: 10.1007/s13277-015-4198-0. Epub 2015 Oct 13.
3
Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer.VEGF和内皮抑素对肺癌患者恶性胸腔积液的预后价值。
Asian Pac J Cancer Prev. 2014;15(19):8435-40. doi: 10.7314/apjcp.2014.15.19.8435.
4
Role of VEGF and CD44v6 in differentiating benign from malignant ascites.血管内皮生长因子(VEGF)和CD44v6在鉴别良性与恶性腹水方面的作用
World J Gastroenterol. 2003 Nov;9(11):2596-600. doi: 10.3748/wjg.v9.i11.2596.
5
Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.血管内皮生长因子和内皮抑素在恶性胸腔积液中的诊断价值
Int J Tuberc Lung Dis. 2009 Mar;13(3):381-6.
6
A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.C反应蛋白与血管内皮生长因子联合用于腹水鉴别诊断的新组合
J Gastrointest Cancer. 2017 Mar;48(1):50-57. doi: 10.1007/s12029-016-9873-x.
7
Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.血管内皮生长因子mRNA和内皮抑素mRNA在肺癌患者胸腔积液中的转录表达及临床意义
Diagn Cytopathol. 2012 Apr;40(4):287-91. doi: 10.1002/dc.21546. Epub 2010 Oct 26.
8
Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.血管内皮生长因子(VEGF)水平作为鉴别恶性腹水和非恶性腹水的一种工具。
APMIS. 2004 Sep;112(9):585-7. doi: 10.1111/j.1600-0463.2004.apm1120904.x.
9
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.IV期透明细胞肾癌患者血清内皮抑素水平升高,且与血清血管内皮生长因子水平相关。
Clin Cancer Res. 2000 Dec;6(12):4628-34.
10
Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer.血管内皮生长因子和内皮抑素在尿液中对膀胱癌诊断的临床价值。
Tumori. 2012 Nov;98(6):762-7. doi: 10.1177/030089161209800614.

引用本文的文献

1
The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment.癌症的预后取决于肿瘤微环境中自噬、细胞凋亡和失巢凋亡的相互作用。
Cell Biochem Biophys. 2023 Dec;81(4):621-658. doi: 10.1007/s12013-023-01179-4. Epub 2023 Oct 3.
2
Development and validation a simple model for identify malignant ascites.开发并验证一种简单的模型用于识别恶性腹水。
Int J Med Sci. 2021 Mar 3;18(9):1966-1974. doi: 10.7150/ijms.53743. eCollection 2021.
3
Acellular fraction from malignant effusions has cytotoxicity in breast cancer cells.

本文引用的文献

1
Role of cholesterol determination in ascitic fluid analysis.胆固醇测定在腹水分析中的作用。
Hepatology. 2009 Oct;50(4):1320. doi: 10.1002/hep.23213.
2
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas.垂体腺瘤患者血清内皮抑素水平升高,且与血清血管内皮生长因子水平相关。
Pituitary. 2005;8(2):163-8. doi: 10.1007/s11102-005-5258-z.
3
Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
恶性胸腔积液的无细胞成分对乳腺癌细胞具有细胞毒性。
Mol Clin Oncol. 2021 May;14(5):106. doi: 10.3892/mco.2021.2268. Epub 2021 Mar 20.
4
Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites.腹腔内贝伐珠单抗治疗难治性恶性腹水的 I 期研究。
J Int Med Res. 2021 Feb;49(2):300060520986664. doi: 10.1177/0300060520986664.
5
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.腹水调节癌细胞行为,导致卵巢癌肿瘤异质性。
Cancer Sci. 2016 Sep;107(9):1173-8. doi: 10.1111/cas.12987. Epub 2016 Aug 16.
6
Diagnostic accuracy of ascitic cholesterol concentration for malignant ascites: a meta-analysis.腹水胆固醇浓度对恶性腹水的诊断准确性:一项荟萃分析。
Int J Clin Exp Med. 2015 Oct 15;8(10):18494-9. eCollection 2015.
7
Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*: A Prospective Substudy of a Randomized Controlled Trial.上皮性卵巢癌手术中恶性腹水的血流动力学后果*:一项随机对照试验的前瞻性子研究
Medicine (Baltimore). 2015 Dec;94(49):e2108. doi: 10.1097/MD.0000000000002108.
8
The clinical significance of vascular endothelial growth factor in malignant ascites.血管内皮生长因子在恶性腹水中的临床意义
Tumour Biol. 2016 Mar;37(3):3719-25. doi: 10.1007/s13277-015-4198-0. Epub 2015 Oct 13.
9
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.内皮抑素在血管生成、淋巴管生成、疾病及临床应用中的新作用。
Biochim Biophys Acta. 2015 Dec;1850(12):2422-38. doi: 10.1016/j.bbagen.2015.09.007. Epub 2015 Sep 12.
10
Anoikis resistance: an essential prerequisite for tumor metastasis.失巢凋亡抗性:肿瘤转移的必要前提条件。
Int J Cell Biol. 2012;2012:306879. doi: 10.1155/2012/306879. Epub 2012 Feb 23.
血管内皮生长因子(VEGF)水平作为鉴别恶性腹水和非恶性腹水的一种工具。
APMIS. 2004 Sep;112(9):585-7. doi: 10.1111/j.1600-0463.2004.apm1120904.x.
4
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.血管内皮生长因子在卵巢癌腹膜播散过程中激活腹水中的基质金属蛋白酶。
Oncol Rep. 2003 Jan-Feb;10(1):89-95.
5
Angiogenesis in epithelian ovarian cancer.上皮性卵巢癌中的血管生成
Mol Pathol. 2002 Dec;55(6):348-59. doi: 10.1136/mp.55.6.348.
6
Structure and function of collagen-derived endostatin inhibitors of angiogenesis.胶原蛋白衍生的血管生成内皮抑素抑制剂的结构与功能
IUBMB Life. 2002 Feb;53(2):77-84. doi: 10.1080/15216540211466.
7
Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma.循环血管生成细胞因子作为头颈部鳞状细胞癌的肿瘤标志物和预后因素
Clin Otolaryngol Allied Sci. 2002 Feb;27(1):32-7. doi: 10.1046/j.0307-7772.2001.00519.x.
8
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.血浆内皮抑素在急性髓系白血病/骨髓增生异常综合征中的临床意义
Cancer. 2002 Jan 1;94(1):14-7. doi: 10.1002/cncr.10200.
9
Serum endostatin correlates with progression and prognosis of non-small cell lung cancer.血清内皮抑素与非小细胞肺癌的进展及预后相关。
Lung Cancer. 2002 Jan;35(1):29-34. doi: 10.1016/s0169-5002(01)00285-9.
10
Malignant ascites: new concepts in pathophysiology, diagnosis, and management.恶性腹水:病理生理学、诊断及管理的新概念
Arch Intern Med. 2001;161(22):2733-7. doi: 10.1001/archinte.161.22.2733.